Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation

NCT01697319 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Mucopolysaccharidosis IVA
Morquio A Syndrome
MPS IVA

Interventions

DRUG: BMN 110

Sponsor

BioMarin Pharmaceutical